# Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder

> **NCT02431845** · NA · RECRUITING · sponsor: **Severance Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** SSRIs

## Key facts

- **NCT ID:** NCT02431845
- **Lead sponsor:** Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-01-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02431845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02431845, "Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02431845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*